drugset / Trial / NCT06484192
Pain Control After Lumbar Spine Fusion
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this randomized controlled trial is to determine if patients who receive non-steroidal anti-inflammatory medications (NSAIDs) following elective lumbar spinal fusion have increased rates of symptomatic nonunion requiring revision spinal surgery at two-years follow-up, compared to those who do not receive NSAIDs.
Timeline
- Start
- 2024-06-28
- Primary completion
- 2025-06-30
- Completion
- 2025-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketorolac | Other / unclassified | 15 mg | — |
| Comparator | Naproxen | Small molecule | 500 mg | — |
| Comparator | Metaxalone | Small molecule | 800 mg | — |
| Comparator | Oxycodone | Other / unclassified | 5 mg | — |
Indications
No indication recorded.